Supplemental D ata Figure 2

Nov 13, 2014

20 likes | 189 Vues

Supplemental Data Figure 2 Frequency distribution of overall repeat HbA1c request intervals (in days). Supplemental D ata Figure 2.

Share Presentation

Embed Code

Link

supplemental
ata figure 2
repeat hba1c request intervals

montana-irwin

Télécharger la présentation

Supplemental D ata Figure 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Supplemental Data Figure 2 Frequency distribution of overall repeat HbA1c request intervals (in days)
Supplemental Data Figure 2

- Supplemental Figure 2 -

TRANSGENIC RESEARCH The production of male-sterile wheat plants through split barnase expression is promoted by the insertion of introns and flexible peptide linkers Katja Kempe, Myroslava Rubtsova, David Riewe and Mario Gils

146 views • 1 slides

Supplemental figure 2.

Supplemental figure 2. 1 2 3 4 5 6. 1 2 3 4 5 6. 1 2 3 4 5 6. Genomic DNA. Fvg8642. Fvg12211. FvTox1. Fvg8644. Fvg13072. Fvg229. Fvg9779. Fvg13120. Fvg2963. Fvg9838. Fvg13121. Fvg9849. Fvg3084. Fvg13122. Fvg4581. Fvg10823.

92 views • 1 slides

Supplemental Figure 2

Supplemental Figure 2. A. C. B.

76 views • 1 slides

Supplemental Figure 2

Supplemental Figure 2. A).

92 views • 1 slides

Supplemental Figure 2.

MS/MS spectrum of a single peptide that identified a protein. The b and y ion series, ion scores, and ranking in the Mascot search were manually inspected. Supplemental Figure 2. Spot 6069. Spot 5331. Spot 3696. Spot 5018. Spot 4068.

216 views • 6 slides

Supplemental Figure 2

MK-1775. MK-1775 + 37.5 nM MK-8776. MK-1775 + 75 nM MK-8776. MK-1775 + 150 nM MK-8776. MK-1775 + 300 nM MK-8776. Supplemental Figure 2. A. B. HRE cells. fractional proliferation. MK-8776 ( μ M). MK-1775 ( μ M).

112 views • 1 slides

Supplemental Figure 2

Supplemental Figure 2. Supplemental Figure 2. Combined use of crizotinib or TAS-115 with erlotinib reverses resistance to EGFR-TKI induced by exogenous HGF on HCC827 cell.

166 views • 1 slides

Supplemental Figure 2

Supplemental Figure 2. FEMALES. MALES. A. **. **. **. **. BARNES. 3. 3. *. ##. M. M. B. $. $. 18. M. C. *. HPWM.

95 views • 1 slides

Supplemental Figure 2

73 views • 2 slides

Supplemental Figure 2

si RNA #1. si RNA #1. si RNA #1. si RNA #1. si RNA #2. si RNA #2. si RNA #2. si RNA #2. si RNA #3. si RNA #3. si RNA #3. si RNA #3. si control. si control. si control. si control. Casp-9. Casp-2. 47kDa. 51kDa. b -actin. b -actin. Relative mRNA expression. RAIDD. PIDD.

129 views • 1 slides

Supplemental D ata Figure 1A

115 views • 3 slides

Supplemental Figure 2

Supplemental Figure 2. B. A.

73 views • 1 slides

Supplemental Figure 2

Supplemental Figure 2. EPO::miR-125b. EPOR::miR-125b.

94 views • 1 slides

Supplemental figure 2

Supplemental figure 2. WT. ARKO. B. C. ArEx2-F. ArEx4-R. loxP. loxP. wt Ar. wt AR. Exon 2. Exon 3. Exon 4. Ex3∆Ar.  -actin. Systemic DMBA treatment. Tumor detection. Ex3∆AR. Collection. Exon 4. Exon 2. A. 8. 9. 10. 11. 12. 13. 14. 15. Up to 39. Age (weeks).

101 views • 1 slides

Supplemental Figure:2

B. Fold Change. Fold Change. CREBH-N. CHOP. ATF4. sXBP1. ATF6 α -N. Fold Change. Fold Change. α - tubulin. α - tubulin. α - tubulin. Supplemental Figure:2. α - tubulin. α - tubulin. A. *. *. *. -. -. -. +. +. +. -. -. +. +. Empty vector. Empty vector. +. -. D. -.

124 views • 1 slides

Supplemental Figure 2

Supplemental Figure 2. Training Set molecules. Macrolide Antibiotics. . . . Erythromycin. Clarithromycin. . Troleandomycin. Calcium Channel Blockers. . Amlodipine. Diltiazem. . Verapamil. Nifedipine. CNS Drugs. MDE. R,S-methylenedioxymethamphetamine (MDMA). Fluoxetine.

203 views • 7 slides

Supplemental Figure 2

Molecularly defined. NKCL. Median expression.  -ENKTL. NKCL. CT( α  ) -PTCL. Median expression. CT( α  )-PTCL. NKCL.  -ENKTL. -SIGLEP3 -ITAGD -KIR2DL4 -TCR-  -KLRC3 -KLRC4 -IL34 -IL18BP -CSTW -CXCL3.  -PTCL (NHS). CT( α  ) -PTCL. -PTCL (NHS). CT( α  ) -PTCL.

122 views • 1 slides

Supplemental Figure 2

wt apaf-1 -/- p53 -/-. Pro-casp8 p48. unspecific band. ERK2. TPT (h). C 8 24 C 8 24 C 8 24. Supplemental Figure 2.

96 views • 1 slides

Supplemental figure 2

Supplemental figure 2. A. DAPI. H3K9me3. DAPI. HP1 . Parp-1 +/+ ; SirT1 +/+. Parp-1 -/- ; SirT1 +/+. B. dapi. EGFP-Parp-1. H3K9me3. a. b. c. dapi. H3K9me3. GST-Parp-1. d. e. f.

145 views • 1 slides

Supplemental Figure 2

Supplemental Figure 2. A B. Saline Saline/RT MnP MnP /RT. Saline Saline/RT MnP MnP /RT. C D. Saline Saline/RT MnP MnP /RT. Saline Saline/RT MnP MnP /RT. Supplemental Figure 2.

103 views • 3 slides

Supplemental Figure 2

Supplemental Figure 2.

85 views • 1 slides

Supplemental Figure 2

Supplemental Figure 2. a. ADP titration (Clark-type electrode). ~10.00. ~10.27. ~7.01. ~5.11. ~5.00. ~4.03. ADP titration (Seahorse XF24). b. ~3.89. ~3.10. ~2.62. ~2.03. ~1.63. c. Mitochondrial integrity test (Clark-type electrode). d.

115 views • 2 slides

More Related